Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 1250.00 | 894.42 | 2043.00 | 2189.25 | 0.9332 | 0.8957 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 1250.00 | 894.42 | 2192.00 | 2189.25 | 1.0013 | 1.0019 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 1250.00 | 894.42 | 1189.00 | 2189.25 | 0.5431 | 0.2466 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 1250.00 | 894.42 | 1435.00 | 2189.25 | 0.6555 | 0.4421 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 1250.00 | 894.42 | 2130.00 | 2189.25 | 0.9729 | 0.9580 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 1250.00 | 894.42 | 718.00 | 2189.25 | 0.3280 | -0.1564 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 1250.00 | 894.42 | 2294.00 | 2189.25 | 1.0478 | 1.0737 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 1250.00 | 894.42 | 2122.00 | 2189.25 | 0.9693 | 0.9523 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 1250.00 | 894.42 | 2169.00 | 2189.25 | 0.9908 | 0.9857 |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 1250.00 | 894.42 | 1019.00 | 2189.25 | 0.4655 | 0.1063 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2022.00 | 2189.25 | 0.9236 | 0.8806 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1921.00 | 2189.25 | 0.8775 | 0.8075 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4035.00 | 4404.75 | 0.9161 | 0.8558 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4337.00 | 4404.75 | 0.9846 | 0.9737 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 2500.00 | 1955.17 | 4329.00 | 4404.75 | 0.9828 | 0.9706 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 2500.00 | 1955.17 | 2272.00 | 4404.75 | 0.5158 | 0.1368 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 2500.00 | 1955.17 | 3697.00 | 4404.75 | 0.8393 | 0.7223 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 2500.00 | 1955.17 | 4359.00 | 4404.75 | 0.9896 | 0.9823 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 2500.00 | 1955.17 | 2196.00 | 4404.75 | 0.4986 | 0.1042 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 2500.00 | 1955.17 | 4528.00 | 4404.75 | 1.0280 | 1.0477 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 2500.00 | 1955.17 | 4461.00 | 4404.75 | 1.0128 | 1.0218 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4778.00 | 4404.75 | 1.0847 | 1.1438 | |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 2500.00 | 1955.17 | 4173.00 | 4404.75 | 0.9474 | 0.9098 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 4701.00 | 4404.75 | 1.0673 | 1.1142 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 2197.00 | 4404.75 | 0.4988 | 0.1046 |